Why is Aurobindo Pharma falling/rising?

As of 16-Jul, Aurobindo Pharma Ltd. is experiencing a slight decline in its stock price, currently at 1,152.90, reflecting a decrease of 1.1 points or 0.1%. The stock has shown a trend reversal, falling after two consecutive days of gains. It is currently trading above its 5-day and 20-day moving averages but below its 50-day, 100-day, and 200-day moving averages. Additionally, there has been a decrease in investor participation, with delivery volume falling by 8.24% against the 5-day average. Over the past year, the stock has generated a return of -16.00%, despite a 5.3% increase in profits, indicating a challenging performance relative to its historical valuation metrics. The company maintains a low debt-to-equity ratio and high institutional holdings at 41.57%, which may provide some stability amidst the current price fluctuations.
In the broader market context, Aurobindo Pharma's short-term performance has been relatively better than the benchmark Sensex, with a 1-week return of +0.87% compared to the Sensex's -1.08%. However, the stock has underperformed over longer periods, with a year-to-date return of -13.65% against the Sensex's +5.75%. This contrast highlights the stock's struggles despite some positive fundamentals, such as an attractive valuation and rising profits, which may not be enough to offset the negative sentiment reflected in its recent price movements.